UGI.F Sugi Holdings Co.Ltd
- Market cap
- EUR 2.94B
- P/E
- 18.0x
- P/B
- 1.58x
- ROE
- 8.2%
- Dividend yield
- 1.28%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Aug 2026.
Is UGI.F undervalued?
Graham numberUGI.F trades 12.1% above its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Sugi Holdings Co.Ltd fundamental analysis
No fundamental analysis for Sugi Holdings Co.Ltd yet.
Sugi Holdings Co.Ltd stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Sugi Holdings Co.Ltd
Sugi Holdings Co.,Ltd. operates drugstores in Japan. The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services. In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreig…
Full company profileSugi Holdings Co.Ltd financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 2 quarters up to Aug 31, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Sugi Holdings Co.Ltd annual financial statements (JPY; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 431B | 457B | 488B | 542B | 603B | 625B | 668B | 744B | 878B | 1.01T | 1.08T |
| Gross Profit | 120B | 132B | 142B | 162B | 181B | 191B | 203B | 229B | 275B | 321B | 338B |
| Operating Income | 22.8B | 24.8B | 25.8B | 29.8B | 33.7B | 32.1B | 31.7B | 36.6B | 42.6B | 48.6B | 49.5B |
| EBITDA | - | 31.0B | 33.5B | 38.4B | 41.5B | 38.7B | 40.6B | 46.3B | 56.2B | 66.2B | 43.6B |
| Net Income | 14.9B | 16.4B | 17.9B | 20.8B | 21.1B | 19.4B | 19.0B | 22.0B | 25.7B | 45.0B | 26.0B |
| EPS | 236 | 259 | 290 | 336 | 342 | 314 | 315 | 121 | 142 | 249 | 70 |
| Balance Sheet | |||||||||||
| Total Assets | 231B | 254B | 265B | 314B | 346B | 335B | 352B | 391B | 495B | 614B | 630B |
| Total Liabilities | 81.9B | 91.9B | 98.9B | 131B | 145B | 121B | 135B | 157B | 244B | 324B | 314B |
| Shareholders' Equity | 149B | 162B | 167B | 183B | 201B | 214B | 217B | 233B | 251B | 290B | 316B |
| Cash & Short-term Investments | 66.4B | 75.7B | 65.3B | 81.3B | 86.8B | 62.8B | 62.6B | 43.4B | 52.8B | 111B | 119B |
| Cash Flow | |||||||||||
| Operating Cash Flow | 16.9B | 27.6B | 22.9B | 45.4B | 34.0B | 7.17B | 38.3B | 39.0B | 36.9B | 86.8B | - |
| Capital Expenditure | 11.9B | 10.8B | 17.1B | 19.4B | 18.6B | 20.7B | 21.5B | 32.7B | 26.0B | 25.7B | 0.00 |
| Free Cash Flow | - | 15.8B | 4.82B | 25.0B | 12.5B | -16.2B | 16.8B | 6.34B | 10.9B | 61.0B | - |
| Ratios | |||||||||||
| ROE | 10.0% | 10.1% | 10.8% | 11.4% | 10.5% | 9.1% | 8.8% | 9.4% | 10.2% | 15.5% | 8.2% |
| ROA | 6.5% | 6.5% | 6.8% | 6.6% | 6.1% | 5.8% | 5.4% | 5.6% | 5.2% | 7.3% | 4.1% |
| Net Profit Margin | 3.5% | 3.6% | 3.7% | 3.8% | 3.5% | 3.1% | 2.8% | 3.0% | 2.9% | 4.5% | 2.4% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Sugi Holdings Co.Ltd dividends
- Dividend yield
- 1.28%
- Forward dividend
- 0.10 EUR
- Payout ratio
- 14.1%
- Ex-dividend date
- Feb 25, 2027
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | JPY 6.33B | 35 | 14.1% |
| 2025 | JPY 5.13B | 28 | 20.0% |
| 2024 | JPY 4.83B | 27 | 22.0% |
| 2023 | JPY 4.91B | 81 | 25.8% |
| 2022 | JPY 4.94B | 80 | 25.5% |
| 2021 | JPY 4.94B | 80 | 23.4% |
| 2020 | EUR 4.63B | 75 | 22.3% |
| 2019 | EUR 4.38B | 71 | 24.4% |
| 2018 | EUR 3.17B | 50 | 19.3% |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 2:1 on Aug 28, 2026.
Who owns Sugi Holdings Co.Ltd
- Insiders 39.44%
- Institutions 33.07%
- Public & others 27.49%
- Shares outstanding 372M
- Free float 211M
Sugi Holdings Co.Ltd company profile
- Company name
- Sugi Holdings Co.Ltd
- Ticker
- UGI.F
- ISIN
- JP3397060009
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Consumer Staples Distribution & Retail
- Employees
- 13,417
- Fiscal year end
- February
- Address
- 62-1 Shin'e, Obu, Japan, 474-0011
- Phone
- 81 5 6245 2700
- Website
- sugi-hd.co.jp
About Sugi Holdings Co.Ltd
Sugi Holdings Co.,Ltd. operates drugstores in Japan. The company also provides self-care support services, including meal delivery, cancer and other health checkups, specific health guidance, health information, and community comprehensive agreements; home-visit dispensing and nursing, prevention programs, shopping assistance, and mobility support services. In addition, it engages in drugstore operation, dispensing pharmacy operation, medical consultation, business in foreign countries, Chinese medicine pharmacy operations, disease prevention and health support, promotion of disabled employment, home visit nursing and elderly home-care support, support for commencement of medical practice, comprehensive staff agency service, and support business for pharmacy operations. Sugi Holdings Co.,Ltd. was founded in 1976 and is headquartered in Obu, Japan.
Sugi Holdings Co.Ltd management
10- Mr. Katsunori SugiuraPresident & Representative Director · born 1978
- Mr. Makoto KasaiCFO & Executive Officer
- Ms. Mari KonagayaExecutive Officer & GM of Legal Affairs Department
- Mr. Shigeki MoriExecutive Officer & CHRO
- Mr. Shinya SugiuraSenior VP & Director · born 1979
- Kazuya MorinagaExecutive Officer · born 1966
- Tsuyoshi YamamotoExecutive Officer
- Tomohiro ShiraishiExecutive Officer
- Mr. Toshiyuki AzeoExecutive Officer
- Mr. Kenta MoriiExecutive Officer